Neuberger Berman Group LLC Embecta Corp. Transaction History

Neuberger Berman Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$15.0 - $22.17 $68,550 - $101,316	-4,570 Reduced 4.79%	90,840 $1.37 Million
Q2 2023 Aug 11, 2023	SELL	$21.6 - $30.69 $33,847 - $48,091	-1,567 Reduced 1.62%	95,410 $2.06 Million
Q1 2023 May 12, 2023	SELL	$23.07 - $32.77 $36,196 - $51,416	-1,569 Reduced 1.59%	96,977 $2.73 Million
Q4 2022 Feb 13, 2023	SELL	$25.29 - $35.48 $37,429 - $52,510	-1,480 Reduced 1.48%	98,546 $2.49 Million
Q3 2022 Nov 15, 2022	SELL	$24.0 - $33.42 $66,192 - $92,172	-2,758 Reduced 2.68%	100,026 $2.88 Million
Q2 2022 Aug 15, 2022	BUY	$24.78 - $33.36 $2.55 Million - $3.43 Million	102,784 New	102,784 $2.61 Million

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.